Skip to main content
Top
Published in: International Urology and Nephrology 3/2017

01-03-2017 | Urology - Original Paper

Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China

Authors: Qing Zhang, Wei Wang, Bing Zhang, Jong Shi, Yao Fu, Danyan Li, Suhan Guo, Shengjie Zhang, Haifeng Huang, Xuping Jiang, Weimin Zhou, Hongqian Guo

Published in: International Urology and Nephrology | Issue 3/2017

Login to get access

Abstract

Objectives

To prospectively compare biopsy outcomes between free-hand transperineal mpMRI/TRUS fusion targeted biopsy (TB) and transperineal systematic biopsy (SB) in patients with first prostate biopsy.

Patients and methods

In all, 224 consecutive patients with the suspicion of PCa were investigated. All patients were evaluated by 3.0-T mpMRI applying the ESUR criteria. All patients underwent free-hand transperineal mpMRI/TRUS fusion TB and additionally a transperineal SB. Pathological findings of TB, SB, and step-sectioned RP specimens were analyzed.

Results

The median age of the patients was 69 (40–85) years, median PSA level was 10.05 (3.61–78.39) ng/mL, and median prostate volume was 45.5 (22–77) mL. Overall, the PCa detection rate was 50.45% (113/224). TB detected significantly more cancer [44.2% (99/224) vs. 34.8% (78/224); P = 0.001] and clinically significant PCa [75.75% (75/99) vs. 62.82% (49/78); P = 0.005] than SB. For the upgrading of Gleason score, 39.74% (31/78), more clinically significant PCa was detected by using additional TB than by SB alone. Conversely, 5.05% (5/99) more clinically significant PCa was found by SB in addition to that by TB. The location of 96.67% (58/60) and Gleason score of 60% (36/60) of TB-proven ITs were correctly identified, as corroborated by RP specimens. The median IT volume was 1.125 (0.21–19.87) ml on MRI and 1.41 (0.13–9.56) ml in RP specimens.

Conclusions

Free-hand transperineal mpMRI/TRUS fusion biopsy was associated with a higher detection rate of clinically significant PCa while taking fewer cores. Moreover, this technique can reliably predict the location, and relatively reliably predict cancer volume and Gleason score of ITs.
Literature
1.
go back to reference Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079–1092CrossRefPubMed Center MM, Jemal A, Lortet-Tieulent J et al (2012) International variation in prostate cancer incidence and mortality rates. Eur Urol 61(6):1079–1092CrossRefPubMed
2.
go back to reference Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397CrossRefPubMedPubMedCentral Siddiqui MM, Rais-Bahrami S, Turkbey B et al (2015) Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA 313(4):390–397CrossRefPubMedPubMedCentral
4.
go back to reference Kaufmann S, Kruck S, Kramer U et al (2015) Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies. Urol Int 94(3):319–325CrossRefPubMed Kaufmann S, Kruck S, Kramer U et al (2015) Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies. Urol Int 94(3):319–325CrossRefPubMed
5.
go back to reference Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67(4):787–794CrossRefPubMed Baco E, Ukimura O, Rud E et al (2015) Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. Eur Urol 67(4):787–794CrossRefPubMed
6.
go back to reference Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140CrossRefPubMed Moore CM, Robertson NL, Arsanious N et al (2013) Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 63(1):125–140CrossRefPubMed
7.
go back to reference Fiard G, Hohn N, Descotes JL, Rambeaud JJ, Troccaz J, Long JA (2013) Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Urology 81(6):1372–1378CrossRefPubMed Fiard G, Hohn N, Descotes JL, Rambeaud JJ, Troccaz J, Long JA (2013) Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Urology 81(6):1372–1378CrossRefPubMed
8.
go back to reference Borkowetz A, Platzek I, Toma M et al (2015) Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int 116(6):873–879CrossRefPubMed Borkowetz A, Platzek I, Toma M et al (2015) Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int 116(6):873–879CrossRefPubMed
9.
go back to reference Siddiqui MM, Rais-Bahrami S, Truong H et al (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64(5):713–719CrossRefPubMed Siddiqui MM, Rais-Bahrami S, Truong H et al (2013) Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 64(5):713–719CrossRefPubMed
10.
go back to reference Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64(4):544–552CrossRefPubMed Moore CM, Kasivisvanathan V, Eggener S et al (2013) Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. Eur Urol 64(4):544–552CrossRefPubMed
11.
go back to reference Zhang Q, Wang W, Yang R et al (2015) Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China. Int Urol Nephrol 47(5):727–733CrossRefPubMed Zhang Q, Wang W, Yang R et al (2015) Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China. Int Urol Nephrol 47(5):727–733CrossRefPubMed
13.
go back to reference Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269(2):482–492CrossRefPubMed Rosenkrantz AB, Kim S, Lim RP et al (2013) Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 269(2):482–492CrossRefPubMed
14.
go back to reference Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–E42CrossRefPubMed Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–E42CrossRefPubMed
15.
go back to reference Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271(5):368–374CrossRefPubMed Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271(5):368–374CrossRefPubMed
16.
go back to reference Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 Suppl):933–938CrossRefPubMed Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 Suppl):933–938CrossRefPubMed
17.
go back to reference Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) consensus confrerence on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29(9):1228–1242CrossRefPubMed Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL (2005) The 2005 International Society of Urological Pathology (ISUP) consensus confrerence on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29(9):1228–1242CrossRefPubMed
18.
go back to reference Dickinson L, Ahmed HU, Allen C et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59(4):477–494CrossRefPubMed Dickinson L, Ahmed HU, Allen C et al (2011) Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 59(4):477–494CrossRefPubMed
19.
go back to reference Perera M, Lawrentschuk N, Bolton D, Clouston D (2014) Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens. BJU Int 113(Suppl 2):29–34CrossRefPubMed Perera M, Lawrentschuk N, Bolton D, Clouston D (2014) Comparison of contemporary methods for estimating prostate tumour volume in pathological specimens. BJU Int 113(Suppl 2):29–34CrossRefPubMed
20.
go back to reference Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178(3 Pt 2):S14–S19CrossRefPubMedPubMedCentral Cooperberg MR, Broering JM, Kantoff PW, Carroll PR (2007) Contemporary trends in low risk prostate cancer: risk assessment and treatment. J Urol 178(3 Pt 2):S14–S19CrossRefPubMedPubMedCentral
21.
go back to reference Bjurlin MA, Carter HB, Schellhammer P et al (2013) Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 189(6):2039–2046CrossRefPubMedPubMedCentral Bjurlin MA, Carter HB, Schellhammer P et al (2013) Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 189(6):2039–2046CrossRefPubMedPubMedCentral
22.
go back to reference Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892CrossRefPubMed Loeb S, Vellekoop A, Ahmed HU et al (2013) Systematic review of complications of prostate biopsy. Eur Urol 64(6):876–892CrossRefPubMed
23.
go back to reference Mendhiratta N, Rosenkrantz AB, Meng X et al (2015) Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification. J Urol 194(6):1601–1606CrossRefPubMed Mendhiratta N, Rosenkrantz AB, Meng X et al (2015) Magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in a consecutive cohort of men with no previous biopsy: reduction of over detection through improved risk stratification. J Urol 194(6):1601–1606CrossRefPubMed
24.
go back to reference Valerio M, Donaldson I, Emberton M et al (2015) Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68(1):8–19CrossRefPubMed Valerio M, Donaldson I, Emberton M et al (2015) Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: a systematic review. Eur Urol 68(1):8–19CrossRefPubMed
25.
go back to reference Thompson JE, Moses D, Shnier R et al (2014) Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol 192(1):67–74CrossRefPubMed Thompson JE, Moses D, Shnier R et al (2014) Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol 192(1):67–74CrossRefPubMed
26.
go back to reference Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361(17):1704–1706CrossRefPubMed Ahmed HU (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361(17):1704–1706CrossRefPubMed
27.
28.
go back to reference Ahmed HU, Arya M, Freeman A, Emberton M (2012) Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy. Lancet Oncol 13(11):e509–e517CrossRefPubMed Ahmed HU, Arya M, Freeman A, Emberton M (2012) Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy. Lancet Oncol 13(11):e509–e517CrossRefPubMed
29.
go back to reference Turkbey B, Mani H, Aras O et al (2012) Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 188(4):1157–1163CrossRefPubMed Turkbey B, Mani H, Aras O et al (2012) Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 188(4):1157–1163CrossRefPubMed
Metadata
Title
Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China
Authors
Qing Zhang
Wei Wang
Bing Zhang
Jong Shi
Yao Fu
Danyan Li
Suhan Guo
Shengjie Zhang
Haifeng Huang
Xuping Jiang
Weimin Zhou
Hongqian Guo
Publication date
01-03-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1484-8

Other articles of this Issue 3/2017

International Urology and Nephrology 3/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine